HPV Vaccine Hesitancy

Findings From a Statewide Survey of Health Care Providers

Annie-Laurie McRee, DrPH; Melissa B. Gilkey, PhD; Amanda F. Dempsey, MD, PhD, MPH


J Pediatr Health Care. 2014;28(6):541-549. 

In This Article

Strengths and Limitations

Study strengths include a large, statewide sample and diversity of respondents with regard to specialty. Limitations include a cross-sectional design and a modest response rate, which may lead to nonresponse bias and limits the generalizability of our findings; however, the cooperation rate among confirmed eligible providers was quite high. Although our study is strengthened by a focus on the target age group for HPV vaccination, previous research consistently finds that providers' recommendation intentions and practices vary by patient age (Allison et al., 2013; Daley et al., 2010; Kahn et al., 2005; Weiss et al., 2010). Future research should investigate HPV vaccine hesitancy among parents of older adolescents, as well as among adolescent patients themselves. Our data are based on providers' self-report, which may be subject to recall and social desirability bias; however, responses were anonymous, reducing this likelihood. Findings regarding nurse practitioners may be skewed because we were not able to distinguish between pediatric and family nurse practitioners in the present study. Finally, because we surveyed health care providers from a single state, the generalizability of the findings to other populations in other regions will need to be established.